Clinical Trial

Le French Gut: Characterization of Gut Microbiota Profiles in France

Recruiting
View on ClinicalTrials.gov →
Summary
" The French Gut " is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project. The main goal of this national trial is a better understanding of the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-24; most recent amendment 2026-06-11.
Trial Details
NCT Number NCT05758961
Lead Sponsor Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Collaborators: Assistance Publique - Hôpitaux de Paris
Conditions General Population
Enrollment 100,000 participants
Start Date 2022-09-15
Primary Completion 2029-09-14 (estimated)
Study Completion 2042-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-15